BOSTON - John Hancock Funds is offering its first biotechnology fund.

The fund will invest in domestic and international companies of all sizes engaged in the research, development, and manufacture of biotech products and services. It will be closed to new investors when assets reach $250 million.

Subscribe Now

Access to authoritative analysis and perspective and our data-driven report series.

14-Day Free Trial

No credit card required. Complete access to articles, breaking news and industry data.